A Study to Test Long-term Treatment With Spesolimab in People With a Skin Condition Disease Called Hidradenitis Suppurativa (HS) Who Took Part in a Previous Study With Spesolimab

NCT06241573 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

39

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Hidradenitis Suppurativa (HS)

Interventions

DRUG: Spesolimab

Sponsor

Boehringer Ingelheim